For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Summary
Market Segment as follows:
By Region
- Asia-Pacific
- North America
- Europe
- South America
- Middle East & Africa
By Type
- Existing Drugs
- Akynzeo (Netupitant-Palonosetron FDC)
- Aloxi (Palonosetron)
- Emend (Aprepitant)
- Kytril Generic (Granisetron)
- Zofran Generic (Ondansetron)
- Pipeline Drugs
- SUSTOL (Granisetron Injection extended release)
- Rolapitant
By Application
- Serotonin Receptor Antagonists
- NK1 Receptor Antagonists
By Company
- Merck & Co., Inc.
- GlaxoSmithKline plc
- Tesaro, Inc.
- Helsinn Group
- F. Hoffmann-La Roche Ltd.
- Heron Therapeutics, Inc.
- Dr. Reddy's Laboratories Ltd.
- Acacia Pharma
- Sun Pharmaceutical Industry Ltd.
- Otsuka Holdings Co., Ltd.
The main contents of the report including:
Section 1: Product definition, type and application, global and regional market overview;
Section 2: Global and regional Market competition by company;
Section 3: Global and regional sales revenue, volume and price by type;
Section 4: Global and regional sales revenue, volume and price by application;
Section 5: Regional export and import;
Section 6: Company information, business overview, sales data and product specifications;
Section 7: Industry chain and raw materials;
Section 8: SWOT and Porter's Five Forces;
Section 9: Conclusion.